Atrial Fibrillation

24 competing products in clinical development for Atrial Fibrillation.

Pipeline by Phase

Pre-clinical9

Phase 25

Phase 38

Approved2

All Products (24)

Product	Company	Stage	Status	Hype
OAC alone	Daiichi Sankyo	Approved	Completed	43
Edoxaban	Daiichi Sankyo	Approved	Completed	43
Edoxaban + Clopidogrel + Prasugrel + Ticagrelor + Vitamin K antagonist	Daiichi Sankyo	Phase 3	Completed	40
Edoxaban + VKA-Based Regimen + VKA-Based Regimen + VKA-Based Regimen + VKA-Based Regimen	Daiichi Sankyo	Phase 3	Completed	40
Edoxaban + Warfarin + Enoxaparin	Daiichi Sankyo	Phase 3	Completed	40
Edoxaban-based Regimen + VKA-based Regimen	Daiichi Sankyo	Phase 3	Completed	40
Du-176b + placebo	Daiichi Sankyo	Phase 3	Completed	40
Vernakalant Injection 20 mg/mL	Astellas Pharma	Phase 3	Completed	40
RSD1235	Astellas Pharma	Phase 3	Completed	40
RSD1235	Astellas Pharma	Phase 3	Completed	40
DU-176b tablets + DU-176b tablets + Warfarin tablets	Daiichi Sankyo	Phase 2	Completed	35
Edoxaban (DU-176b) + Edoxaban (DU-176b) + Edoxaban (DU-176b) + Edoxaban (DU-176b) + warfarin	Daiichi Sankyo	Phase 2	Completed	35
DU-176b tablets + Warfarin potassium tablets	Daiichi Sankyo	Phase 2	Completed	35
YM150 + Warfarin	Astellas Pharma	Phase 2	Completed	35
YM150 + warfarin	Astellas Pharma	Phase 2	Completed	35
Edoxaban + Apixaban + Rivaroxaban	Daiichi Sankyo	Pre-clinical	Completed	26
Edoxaban	Daiichi Sankyo	Pre-clinical	Completed	26
Edoxaban	Daiichi Sankyo	Pre-clinical	Completed	26
Edoxaban	Daiichi Sankyo	Pre-clinical	Completed	26
Edoxaban	Daiichi Sankyo	Pre-clinical	Completed	26
Edoxaban	Daiichi Sankyo	Pre-clinical	Completed	26
Edoxaban	Daiichi Sankyo	Pre-clinical	Completed	26
Edoxaban	Daiichi Sankyo	Pre-clinical	Completed	26
dabigatran, rivaroxaban, apixaban or edoxaban	Daiichi Sankyo	Pre-clinical	UNKNOWN	22